{"name":"BioMendics, LLC","slug":"biomendics-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TolaSure Topical Gel","genericName":"TolaSure Topical Gel","slug":"tolasure-topical-gel","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"TolaSure Topical Gel","genericName":"TolaSure Topical Gel","slug":"tolasure-topical-gel","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOZzE1cmROMWdxQ3JHYi16WkhKZWR0YTU4TVhFamx2SnpOM24zM3B6aFBCRGR5YnZ6eDRTVzlVcE5JRzI3MDU1bU5jR2FUeTNNSWJlY3VKc0lqUzlJS2RlS2JyWU5PZ3hTeXljWTYxX211RXgtcTVLYXp5YjJ2QUtQWUxlcUlzY2lqTVk5UTlGVm5saEpQVjNUajVUR1ZtVGUtTllnRzJTeHdqd2NlWVB6cng0SXlsWTFVaTRyaEZ1NDNLa0JCSFJERjJQZ2lQeXFOaVY5ODBZYjRNc0tpU1ZfR3F5bGNmN1k1RkpnRmtVNmV4UQ?oc=5","date":"2026-01-06","type":"trial","source":"BioSpace","summary":"BioMendics Brings New Hope for Epidermolysis Bullosa Simplex Patients as TAMES‑02 Trial Advances and JPM Week Approaches - BioSpace","headline":"BioMendics Brings New Hope for Epidermolysis Bullosa Simplex Patients as TAMES‑02 Trial Advances and JPM Week Approaches","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQM054RlMxeUpLeFJCT3pOc3BlbGJhV1B4a2k1UXBoZWhwcmVZaVpsLVFWdGNoM0lQbzU5VUNiZF9DeVB1UWVHc3Znb1Q5V0ZORXZiYlJHTEZTUlczQmNvclN2ellIcFh4aGNhQ0h1ZXVZVzhKQjVHbWlLeG56WktPWm43ZDd1RnpBeWMwV3RvYlAzLThxNnVBRVRsNU55MlFMd2F3N1ZVS1JQYlhMVG5RVUFLeW0teHNFMlFjUEktMk9IYmlFeHF0WFF5TzNKZFVNOXo5d0hwUVk4djVxV1ZiWEQwNHNTZDY2UF96bVhUMTNZbEY4Q2Rn?oc=5","date":"2023-10-30","type":"pipeline","source":"BioSpace","summary":"BioMendics to Present on Epidermolysis Bullosa Simplex at the 7th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases - BioSpace","headline":"BioMendics to Present on Epidermolysis Bullosa Simplex at the 7th Annual Dermatology Drug Development Summit for Inflamm","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}